Close
Interim changes to JRO process for reviewing 香港六合彩/香港六合彩H GMO trial risk assessments
24 June 2020
There is a new interim process for submitting risk assessment documents for GMO-IMP trials (clinical trials which use an investigational medicinal product considered to be a genetically modified organism) at 香港六合彩 or 香港六合彩H.
Investigators should now submit documents to the JRO via uclh.randd@nhs.net and mark this as a 'GMO risk assessment'.
Alternatively, 香港六合彩 investigators 鈥� or investigators on 香港六合彩 sponsored trials 鈥� can complete the GM risk assessment form via 香港六合彩 RiskNet. Further details are here.
Previously documents were sent directly to the 香港六合彩/香港六合彩H/RFH Genetic Modification Safety Committee chair Professor Emma Morris, but she has now stepped down from the post.
The Approval of hosted clinical trials using IMPs which are considered to be GMOs 香港六合彩H Policy will be updated in due course.